Telegraph Hill Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Cell Microsystems develops integrated platforms for cell engineering, isolation, culture, and analysis.
BiotechDeep TechMedical DevicesDurham, US
Nancy Allbritton(Director)Yuli Wang(Director)Matthew Megaro(Director)Gary Pace(Executive Officer, Director)Christopher Sims(Executive Officer, Director)
Board seatDeval LashkariRob Capone· per SEC Form D
BiotechSan Diego, US
Robert Finzi(Director)David Wellis, Ph.D.(Executive Officer, Director)Alex Herzik(Director)
Board seatDeval LashkariPaul Grossman· per SEC Form D · $15M raise · filed Nov 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.